Premier Dividend Growth Stocks: Is There Any Value? A Sector By Sector Summary Review: Part 1

Introduction

As a value investor, I must admit to being very frustrated with the valuations I’m seeing on high-quality blue-chip dividend growth stocks.  I have been vigorously searching for fairly valued dividend growth stocks to invest in.  I have thoroughly screened and evaluated every company in the S&P Dividend Aristocrats, all three of the CCC (Champions, Contenders and Challengers) lists produced by David Fish, every dividend paying stock on the S&P 500, Fortune 500, NASDAQ 100, S&P 100 Large-cap, Dow Jones Industrial Average, and even the S&P 400 mid-cap universe.

[…]

Please follow and like us:

Let’s Go Krogering for Value and Profit

Introduction

In today’s frothy stock market, finding value in dividend growth stocks is hard to do.  Unfortunately, most of the premier  dividend growth stocks such as those found on David Fish’s CCC lists of Dividend Champions, Contenders and Challengers are currently overvalued.  Dividend Champions have raised their dividends for 25 or more straight years, Dividend Contenders have raised their dividends for 10 to 24 straight years, and Dividend Challengers for 5 to 9 straight years.

[…]

Please follow and like us:

7 Intriguing Healthcare Growth Stocks in the S&P 500: Part 2

Introduction

The S&P 500 index is commonly used as a benchmark that investors use to measure the performance of their individual portfolios against.  However, the S&P 500 is comprised of a very diverse group of companies.  Just about every classification of company you can imagine can be found in the S&P 500.  Furthermore, it is also comprised of all of the major industry sectors.  With this series of articles, I have been examining the S&P 500 constituents in the healthcare sector.  In part 1, I presented what I consider to be attractively valued dividend growth stocks in the S&P 500 healthcare sector.  In this part 2, I will continue to examine S&P 500 healthcare stocks; however, with this article I will focus on fairly valued non-dividend paying growth-oriented S&P 500 healthcare constituents.

[…]

Please follow and like us:

Finding Value In The S&P 500: 9 Healthcare Dividend Growth Stocks: Part 1

Introduction

Most everyone would agree that the stock market as measured by the S&P 500 is not cheap today.  However, there might be a great deal of disagreement regarding precisely how overvalued the S&P 500 currently is.  Nevertheless, I would agree that in the general sense, stocks are not exactly bargains today.  This might especially be true regarding best-of-breed blue-chip dividend growth stocks.  Low interest rates have enhanced the attraction for high-quality dividend paying stocks.

[…]

Please follow and like us:

FOMC Interest Rates and Their Impact on the US Economy: Part 2

FOMC Interest Rates and Their Impact on the US Economy: Part 2

Introduction

To me, interest rates and their future direction seems to be obsessively discussed and debated by many investors.  So much so, that I often get the impression that many investors believe that interest rates coupled with Federal Reserve policy are the primary drivers of our economy.  From my perspective, interest rates and Federal Reserve monetary policy are contributing factors to economic growth and stability.  However, I would stop short of considering them of primary importance.

[…]

Please follow and like us:

What Will Happen To the Stock Market When Interest Rates Rise? Part 1

Introduction

Interest rates have been in a freefall for the better part of the past two decades.  Moreover, the yield on the 10-year US Treasury, which is the flagship interest rate benchmark, has mostly been below 2% since the beginning of 2012.  The 10-year Treasury note did reach 3% by the end of 2013 but has promptly fallen ever since to its current level of 1.59 percent.

[…]

Please follow and like us:

These Are The Only Dividend Champions And Contenders That Appear Attractively Valued

Introduction

As the stock market continues its relentless advance, attractive valuations are getting harder and harder to find.  This is especially true for the highest quality blue-chip dividend growth stocks.  Perhaps more importantly, in addition to the market’s relentless advance, there has also been a clear flight to quality – especially with dividend growth stocks.  Therefore, the vast majority of the best-of-breed blue-chip dividend paying stocks are currently trading at elevated levels.  In other words, finding high quality and value is very rare today in the dividend growth segment.

[…]

Please follow and like us:

Answers to the Hardest Decision-When Do I Sell A Stock?

Introduction

I’m going to start this article with the same opening statement that I utilized in a previous article I wrote on knowing when to sell a stock. The most common complaint that I have heard from investors over my 40+ years in the financial services industry is as follows: “Everyone wants to tell me what to buy and when, but no one ever tells me when to sell.”  Consequently, it seems to me that whether you are a novice investor or a grizzled old veteran, the decision as to when to sell a stock is considered the most difficult decision investors have to make.

[…]

Please follow and like us:

Get Higher Returns and More Dividend Income – In Less Time With Less Risk

Introduction

Investing in blue-chip dividend growth stocks such as the Dividend Aristocrats or Champions has become very popular with retirees.  This is understandable considering the low interest rate environment we find ourselves in.  Traditional fixed income investments do not currently offer enough yield for the retired investor to live on.  Consequently, current low interest rates, coupled with the possibility of a steadily increasing level of dividend income have made dividend growth stocks a viable and even attractive alternative.

[…]

Please follow and like us:

5 Attractive Biotechnology Stocks for Healthy Long-term Returns

Introduction

I am a fervent believer that investors are best served by investing towards a specific investment objective that suits their own unique goals, objectives and risk tolerance.  In other words, investing is not always trying to get the highest possible total returns.  If that were true, no one would have ever invested in bonds, CDs or other fixed income instruments.

[…]

Please follow and like us: